<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>241362</rcn>
  <id>101069289</id>
  <acronym>Soxradicate Relapse</acronym>
  <teaser>Emergence of therapy resistance is a major cause of death following conventional chemotherapy and radiation for children and adults with malignant brain tumors. It is imperative to find novel options to target therapy-resistant brain tumor populations to save lives. We propose...</teaser>
  <objective>Emergence of therapy resistance is a major cause of death following conventional chemotherapy and radiation for children and adults with malignant brain tumors. It is imperative to find novel options to target therapy-resistant brain tumor populations to save lives. We propose a novel platform providing a prognostic tool and a suicide gene therapy tool using engineered viruses. It involves targeting freshly biopsied cells from brain tumor patients with our strategy in combination with standard therapy to predict risk of patients developing relapse and a gene therapy suicide tool to remove cells causing relapse. 

Previous suicide gene therapies have only used viruses hitting dividing tumor cells. Our strategy will use an enigneered virus targeting non-dividing tumor cells that we know escape standard therapy. After removing the tumor bulk using standard treatment, we propose to use our virus with a marker for diagnostic purposes or a with a suicide gene that will be activated by a prodrug to eradicate therapy-resistant cells. Prodrug administration before recurrence will eliminate relapsed cells once they start dividing and become dangerous.

The impact of our strategy will be high, providing health care professionals with a better tool to identify patients at high risk of developing recurrence. Such patients can receive a better, more tailored treatment that will not only increase their chance of survival but also reduce their time under hospital care and rehabilitation. We protected our strategy with a filed patent and assessed our regulatory needs. We completed a market analysis to evaluate market size and potential benefit for cancer patients. We have disclosed competitors but also potential collaborators that can cofinance and move our strategy forward to in vitro diagnostic device registration and initial clinical trials. In our proposal we will apply for funding covering lab work to test efficacy and safety, help with registration and negotitation strategies.</objective>
  <title>A combined diagnostic and targeted gene therapy platform for brain tumor relapse</title>
  <totalCost>0</totalCost>
  <ecMaxContribution>150000</ecMaxContribution>
  <startDate>2022-09-01</startDate>
  <endDate>2024-02-29</endDate>
  <ecSignatureDate>2022-08-18</ecSignatureDate>
  <duration>18</duration>
  <status>CLOSED</status>
  <identifiers>
    <grantDoi>10.3030/101069289</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2022-08-22 14:35:04</sourceUpdateDate>
  <contentCreationDate>2022-09-04 13:26:32</contentCreationDate>
  <contentUpdateDate>2025-09-01 23:23:07</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:48:36</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <rcn>437926</rcn>
        <id>437926-innovative-therapy-platform-for-brain-tumour-relapse-treatment</id>
        <title>Innovative therapy platform for brain tumour relapse treatment</title>
        <contentUpdateDate>2022-12-23 15:48:02</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode>/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode>/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55465</rcn>
        <title>ERC-2022-POC1</title>
        <identifier>ERC-2022-POC1</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55465</rcn>
        <title>ERC-2022-POC1</title>
        <identifier>ERC-2022-POC1</identifier>
      </call>
      <organization netEcContribution="40000" totalCost="0" source="corda" order="2" ecContribution="40000" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1976818</rcn>
        <id>888893839</id>
        <vatNumber>SE559012332801</vatNumber>
        <legalName>UPPSALA UNIVERSITET RESEARCHINTELLECTUAL PROPERTY AB</legalName>
        <address>
          <street>DAG HAMMARSKJOLDS VAG 38</street>
          <city>Uppsala</city>
          <postalCode>752 37</postalCode>
          <country>SE</country>
          <geolocation>59.7870746,17.6633178</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Uppsala län</name>
              <rcn>473436289</rcn>
              <nutsCode>SE121</nutsCode>
              <parents>
                <region>
                  <name>Östra Mellansverige</name>
                  <rcn>473436328</rcn>
                  <nutsCode>SE12</nutsCode>
                  <parents>
                    <region>
                      <name>Östra Sverige</name>
                      <rcn>473438760</rcn>
                      <nutsCode>SE1</nutsCode>
                      <parents>
                        <region>
                          <name>Sweden</name>
                          <rcn>473598504</rcn>
                          <nutsCode>SE</nutsCode>
                          <euCode>SE</euCode>
                          <isoCode>SE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Sweden</name>
              <rcn>473598504</rcn>
              <nutsCode>SE</nutsCode>
              <euCode>SE</euCode>
              <isoCode>SE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="110000" totalCost="0" source="corda" order="1" ecContribution="110000" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1906665</rcn>
        <id>999985029</id>
        <vatNumber>SE202100293201</vatNumber>
        <legalName>UPPSALA UNIVERSITET</legalName>
        <shortName>UU</shortName>
        <address>
          <street>VON KRAEMERS ALLE 4</street>
          <city>Uppsala</city>
          <postalCode>751 05</postalCode>
          <country>SE</country>
          <postBox>Box 256</postBox>
          <url>http://www.uu.se</url>
          <geolocation>59.8499725,17.6332425</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Uppsala län</name>
              <rcn>473436289</rcn>
              <nutsCode>SE121</nutsCode>
              <parents>
                <region>
                  <name>Östra Mellansverige</name>
                  <rcn>473436328</rcn>
                  <nutsCode>SE12</nutsCode>
                  <parents>
                    <region>
                      <name>Östra Sverige</name>
                      <rcn>473438760</rcn>
                      <nutsCode>SE1</nutsCode>
                      <parents>
                        <region>
                          <name>Sweden</name>
                          <rcn>473598504</rcn>
                          <nutsCode>SE</nutsCode>
                          <euCode>SE</euCode>
                          <isoCode>SE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Sweden</name>
              <rcn>473598504</rcn>
              <nutsCode>SE</nutsCode>
              <euCode>SE</euCode>
              <isoCode>SE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>706226</rcn>
        <id>HORIZON_ERC-2022-POC1</id>
        <code>ERC-2022-POC1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>ERC PROOF OF CONCEPT GRANTS1</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705727</rcn>
        <id>HORIZON.1.1</id>
        <code>HORIZON.1.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.1.1</pga>
        <title>European Research Council (ERC)</title>
        <parent>
          <programme>
            <rcn>705726</rcn>
            <code>HORIZON.1</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1139591</rcn>
        <id>101069289_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - Soxradicate Relapse (A combined diagnostic and targeted gene therapy platform for brain tumor relapse)</title>
        <description>periodic</description>
        <teaser>Tumor relapse is often fatal and leads to death of malignant cancer types, including aggressive brain tumors in both adults and children. Improving prognosis and to identify increased risk of recurrence in patients diagnosed with a malignant brain tumor is lacking. The...</teaser>
        <sourceUpdateDate>2024-07-28 15:35:29</sourceUpdateDate>
        <contentUpdateDate>2024-08-05 12:21:04</contentUpdateDate>
        <relations>
          <associations>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/101069/101069289_PS/simplified-phase-i-trial-rgbm-lcc-therapeutics.png</uri>
              <alternativeText>Proposed simplified clinical trial for LCC Therapeutics for use in relapsed GBM patients</alternativeText>
              <mimetype>image/png</mimetype>
              <size>1160192</size>
            </webItem>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode>/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237405</rcn>
        <id>101069289_3BB9AA33DA64FC8CA27DE7217EE68E94_IPRHORIZON</id>
        <title>PREDICTING CANCER RELAPSE AND TREATMENT OF CANCER DISEASES</title>
        <details>
          <iprAwarded></iprAwarded>
          <iprNumber>766247</iprNumber>
          <iprDate>2021-08-27</iprDate>
          <iprPrefix>21</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1906665</rcn>
              <id>999985029</id>
              <vatNumber>SE202100293201</vatNumber>
              <legalName>UPPSALA UNIVERSITET</legalName>
              <shortName>UU</shortName>
              <address>
                <street>VON KRAEMERS ALLE 4</street>
                <city>Uppsala</city>
                <postalCode>751 05</postalCode>
                <country>SE</country>
                <postBox>Box 256</postBox>
                <url>http://www.uu.se</url>
                <geolocation>59.8499725,17.6332425</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/HES</code>
                    <title>Higher or Secondary Education Establishments</title>
                    <displayCode>/Higher or Secondary Education Establishments</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Uppsala län</name>
                    <rcn>473436289</rcn>
                    <nutsCode>SE121</nutsCode>
                    <parents>
                      <region>
                        <name>Östra Mellansverige</name>
                        <rcn>473436328</rcn>
                        <nutsCode>SE12</nutsCode>
                        <parents>
                          <region>
                            <name>Östra Sverige</name>
                            <rcn>473438760</rcn>
                            <nutsCode>SE1</nutsCode>
                            <parents>
                              <region>
                                <name>Sweden</name>
                                <rcn>473598504</rcn>
                                <nutsCode>SE</nutsCode>
                                <euCode>SE</euCode>
                                <isoCode>SE</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>Sweden</name>
                    <rcn>473598504</rcn>
                    <nutsCode>SE</nutsCode>
                    <euCode>SE</euCode>
                    <isoCode>SE</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode>/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/341/325</code>
        <title>virology</title>
        <displayCode>/natural sciences/biological sciences/microbiology/virology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/227</code>
        <title>physiotherapy</title>
        <displayCode>/medical and health sciences/clinical medicine/physiotherapy</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="40">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-ERC-POC</code>
        <title>HORIZON ERC Proof of Concept Grants</title>
        <description>HORIZON ERC Proof of Concept Grants</description>
        <displayCode>/HORIZON ERC Proof of Concept Grants</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>